#3046
Incidence of Neuroendocrine Neoplasms Reported in England 2015-2017
Introduction:
Previously published UK Cancer Registry data showed incidence of Neuroendocrine Neoplasms rising between 2001 and 2015. This was higher than had been thought (Genus et al). We report more recent data with more accurate coding (ICD-O-3).
Conference:
17th Annual ENETSConcerence (2020)
Presenting Author:
Authors:
White B,
Bouvier C,
Genus T,
Rous B,
Srirajaskanthan R,
Keywords:
Epidemiology,
Neuroendocrine Neoplasia,
Incidence,
Prevalence,
population data,
histopathology,
#3045
Reliability and Agreement of Radiological and Pathological Tumor Size in Patients with MEN1-Related Pancreatic Neuroendocrine Tumors: Results from a Population-Based Cohort
Introduction:
Pancreatic neuroendocrine tumors (pNETs) are the most lethal manifestation in patients with multiple endocrine neoplasia type 1 (MEN1). Tumor size is still regarded as the main prognostic factor and therefore used for surgical decision making.
Conference:
17th Annual ENETSConcerence (2020)
Presenting Author:
van Beek D
Authors:
van Beek D,
Verkooijen H,
Bonsing B,
van Eijck C,
van Goor H,
Keywords:
Multiple endocrine neoplasia type 1,
pancreatic neuroendocrine tumor,
reliability,
agreement,
computed tomography,
magnetic resonance imaging,
endoscopic ultrasonography,
pathology,
#3031
Primitive Peripheral Neuroectodermal Tumor: Case Report
Introduction:
Primitive neuroectodermal tumors belong to the family of Ewing sarcomatous tumors, all derived from the same stem cell. The cells of the neural crest are believed to be at the origin of these tumors. The predilection sites of these sarcomas are para-vertebral region, chest wall and the distal ends. The positive diagnosis of primary neuroectodermal tumors requires the contribution of histopathology, immunohistochemistry and cytogenetics.
Conference:
17th Annual ENETSConcerence (2020)
Presenting Author:
Authors:
Ikram B,
Soumeya G,
Keywords:
Primitive neuroectodermal tumor,
primary,
peripheral,
pPNET,
CD99,
surgery,
chemotherapy,
#3015
Biopsy Specimen Diagnosis in Pulmonary Carcinoids, A Shot in the Dark
Introduction:
Pulmonary carcinoids (PCs) are rare well-differentiated neuroendocrine tumors, which can be separated into typical carcinoid (TC) and atypical carcinoid (AC). Advised treatment for local carcinoid disease is surgical resection using lobectomy, while parenchymal saving strategies such as sub-lobar or endobronchial resection might be considered for TC. In general, pre-operative diagnosis using a (transbronchial/transthoracic) biopsy sample is performed to demonstrate malignancy. However, TC and AC classification can solely be performed on surgical resection specimens, which may challenge pre-operative treatment decisions.
Conference:
17th Annual ENETSConcerence (2020)
Presenting Author:
Moonen L
Authors:
Moonen L,
Derks J,
Hermans B,
Dingemans A,
Speel E,
Keywords:
pulmonary,
neuroendocrine,
carcinoid,
biopsy,
resection,
diagnosis,
